{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T02:46:48Z","timestamp":1774147608275,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120679","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:59:55Z","timestamp":1761868795000},"page":"120679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Incorporating measurement uncertainty into free valproic acid monitoring: estimation and clinical impact for therapeutic drug monitoring"],"prefix":"10.1016","volume":"579","author":[{"given":"Ra\u00fal","family":"Rigo-Bonnin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virg\u00ednia","family":"Mas-Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Blanco-Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120679_bb0005","author":"Rahman"},{"key":"10.1016\/j.cca.2025.120679_bb0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/TME.0000000000000319","article-title":"Valproic acid in the treatment of migraines","volume":"42","author":"Brown","year":"2020","journal-title":"Adv. Emerg. Nurs. J."},{"key":"10.1016\/j.cca.2025.120679_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cca.2025.120679_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-198815060-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"15","author":"Zaccara","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cca.2025.120679_bb0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2710.1993.tb00612.x","article-title":"Plasma protein binding kinetics of valproic acid over a broad dosage range: therapeutic implications","volume":"18","author":"Bellver","year":"1993","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.cca.2025.120679_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","article-title":"Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10","volume":"37","author":"Argikar","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cca.2025.120679_bb0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-4165(90)90079-C","article-title":"The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase","volume":"1034","author":"Ito","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2025.120679_bb0040","first-page":"417","article-title":"CYP2C9*3\/*3 gene expression affects the total and free concentrations of valproic acid in pediatric patients with epilepsy","volume":"14","author":"Wu","year":"2021","journal-title":"Pharmgenomics Pers. Med."},{"key":"10.1016\/j.cca.2025.120679_bb0045","first-page":"236","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics, Pharmacogenet","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Genomics"},{"key":"10.1016\/j.cca.2025.120679_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cca.2025.120679_bb0055","series-title":"Therapeutic Drug Monitoring Data. A Concise Guide","author":"Dasgupta","year":"2020"},{"key":"10.1016\/j.cca.2025.120679_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcrc.2016.06.023","article-title":"Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy","volume":"36","author":"Smetana","year":"2016","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.cca.2025.120679_bb0065","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jfma.2020.09.004","article-title":"Factors influencing the accuracy of albumin adjusted free valproic acid concentration","volume":"120","author":"Tseng","year":"2021","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.cca.2025.120679_bb0070","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1515\/cclm-2019-1336","article-title":"The utility of measurement uncertainty in medical laboratories","volume":"58","author":"Braga","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2025.120679_bb0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2478\/jomb-2018-0002","article-title":"Uncertainty of measurement in laboratory medicine","volume":"37","author":"Milinkovi\u0107","year":"2018","journal-title":"J. Med. Biochem."},{"key":"10.1016\/j.cca.2025.120679_bb0080","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1515\/cclm-2013-0749","article-title":"Estimation of uncertainty in measurements in the clinical laboratory","volume":"51","author":"Kallner","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2025.120679_bb0085","unstructured":"ISO, Medical laboratories \u2013 Requirements for quality and competence. ISO 15189:2022, Geneva: ISO; 2022."},{"key":"10.1016\/j.cca.2025.120679_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117678","article-title":"Development and validation of equilibrium dialysis UHPLC-MS\/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma: application to patients with HIV","volume":"552","author":"Rigo-Bonnin","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120679_bb0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-018-0627-4","article-title":"Accuracy of valproic acid concentration correction based on serum albumin","volume":"30","author":"Drisaldi","year":"2019","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.cca.2025.120679_bb0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S031716710004600X","article-title":"Free valproic acid: steady-state pharmacokinetics in patients with intractable epilepsy","volume":"11","author":"Otten","year":"1984","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.cca.2025.120679_bb0105","first-page":"649","article-title":"Acide valpro\u00efque: estimation simple de la concentration s\u00e9rique libre","volume":"51","author":"Parent","year":"1993","journal-title":"Ann. Biol. Clin. (Paris)"},{"key":"10.1016\/j.cca.2025.120679_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100503","article-title":"A novel method for predicting the unbound valproic acid concentration","volume":"50","author":"Ishikawa","year":"2023","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cca.2025.120679_bb0115","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.2042-7158.1996.tb05901.x","article-title":"Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients","volume":"48","author":"Kodama","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cca.2025.120679_bb0120","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/phar.1965","article-title":"Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia","volume":"37","author":"Dor\u00e9","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cca.2025.120679_bb0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/ejhpharm-2021-003092","article-title":"Design and validation of a predictive equation to estimate unbound valproic acid concentration","volume":"30","author":"Conde Giner","year":"2023","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.cca.2025.120679_bb0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2018.04.012","article-title":"Determinants of free serum valproate concentration: a prospective study in patients on divalproex sodium monotherapy","volume":"59","author":"Nasreddine","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.cca.2025.120679_bb0135","article-title":"Derivation and validation of a new equation for estimating free valproate concentration in critically ill patients","volume":"5","author":"Liu","year":"2023","journal-title":"Crit. Care Explor."},{"key":"10.1016\/j.cca.2025.120679_bb0140","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00228-024-03741-2","article-title":"Therapeutic drug monitoring for valproate: deriving a novel formula for calculation of free concentration","volume":"80","author":"Pretorius","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cca.2025.120679_bb0145","series-title":"International Organization for Standardization, Medical Laboratories \u2013 Practical Guidance for the Estimation of Measurement Uncertainty. ISO\/TS 20914, Geneva: ISO","year":"2019"},{"key":"10.1016\/j.cca.2025.120679_bb0150","series-title":"Joint Committee for Guides in Metrology, Evaluation of measurement data \u2014 Guide to the expression of uncertainty in measurement (GUM). JCGM","volume":"100","year":"2008"},{"key":"10.1016\/j.cca.2025.120679_bb0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clinbiochem.2021.01.005","article-title":"Estimation of the uncertainty of values assigned to calibration materials prepared in-house: an example for hydroxychloroquine calibrators in blood-hemolysate-based matrix","volume":"89","author":"Rigo-Bonnin","year":"2021","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120679_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cca.2019.11.011","article-title":"Different approaches for estimating measurement uncertainty: an effective tool for improving interpretation of results","volume":"503","author":"Zhou","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120679_bb0165","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1515\/cclm-2014-0065","article-title":"Measurement uncertainty and clinical interpretation of measurement results","volume":"52","author":"Fuentes-Arderiu","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2025.120679_bb0170","article-title":"Evaluation of free valproate concentration in critically ill patients","volume":"4","author":"Brown","year":"2022","journal-title":"Crit. Care Explor."},{"key":"10.1016\/j.cca.2025.120679_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238201","article-title":"Safety range of free valproic acid serum concentration in adult patients","volume":"15","author":"Tseng","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2025.120679_bb0180","first-page":"327","article-title":"Heteroscedasticity in clinical laboratory results and its metrological consequences, Accred","volume":"8","author":"Fuentes-Arderiu","year":"2003","journal-title":"Qual. Assur."},{"key":"10.1016\/j.cca.2025.120679_bb0185","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2021.010501","article-title":"Estimation of the measurement uncertainty and practical suggestion for the description of the metrological traceability in clinical laboratories","volume":"31","author":"Rigo-Bonnin","year":"2021","journal-title":"Biochem. Med (Zagreb)."},{"key":"10.1016\/j.cca.2025.120679_bb0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cca.2019.03.1633","article-title":"Bias in analytical chemistry: a review of selected procedures for incorporating uncorrected bias into the expanded uncertainty of analytical measurements and a graphical method for evaluating the concordance of reference and test procedures","volume":"495","author":"Frenkel","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120679_bb0195","article-title":"Evaluation of measurement uncertainty in clinical chemistry and its comparison with analytical performance specifications","volume":"17","author":"Wadhwa","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.cca.2025.120679_bb0200","article-title":"A practical approach to the estimation of measurement uncertainty in clinical laboratories","volume":"32","author":"Tan","year":"2022","journal-title":"Biochem. Med. (Zagreb)."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2025.120679_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003088-198400091-00007","article-title":"Ultrafiltration vs equilibrium dialysis for determination of free fraction","volume":"9","author":"Bowers","year":"1984","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cca.2025.120679_bb0210","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.xphs.2018.10.011","article-title":"Improving confidence in the determination of free fraction for highly bound drugs using bidirectional equilibrium dialysis","volume":"108","author":"Chen","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.cca.2025.120679_bb0215","doi-asserted-by":"crossref","first-page":"12265","DOI":"10.1038\/s41598-020-69102-y","article-title":"Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma drug concentrations: application to dolutegravir","volume":"10","author":"Metsu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120679_bb0220","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1515\/cclm-2023-1023","article-title":"Measurement uncertainty estimation of free drug concentrations in clinical laboratories using equilibrium dialysis","volume":"62","author":"Rigo-Bonnin","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2025.120679_bb0225","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2025-0736","article-title":"Estimation of measurement uncertainty for free drug concentrations using ultrafiltration","author":"Rigo-Bonnin","year":"2025","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:34:55Z","timestamp":1766511295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125005583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S0009898125005583"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120679","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporating measurement uncertainty into free valproic acid monitoring: estimation and clinical impact for therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120679"}}